Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-3 Receptor Alpha Subunit (IL3RA)
- Target
- IL3RA
- Molecular classification
- Type I cytokine receptor, Cell surface receptor, Single-pass type I transmembrane glycoprotein
01
Overview
Interleukin-3 receptor alpha subunit (IL3RA), also known as CD123, is a cell surface glycoprotein that forms part of the heterodimeric receptor complex for interleukin-3 (IL-3). It is a member of the type I cytokine receptor family and plays a critical role in hematopoietic cell signaling, proliferation, survival, and differentiation. It is a therapeutic target in AML and BPDCN.
- Other names
- CD123IL3RIL3RYIL3RAYhIL-3Ra
02
Mechanism of action
Tagraxofusp: Fusion protein of IL-3 and diphtheria toxin, targets and kills CD123-expressing cells. SGN-CD123A: Antibody-drug conjugate, delivers cytotoxic payload to CD123-expressing cells.
03
Biological functions
Signal transductionCell proliferationCell survivalCell differentiationHematopoiesisImmune response regulation
04
Disease associations
Acute Myeloid Leukemia (AML)Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Acute Lymphoblastic Leukemia
05
Safety considerations
On-target, off-tumor toxicity to normal hematopoietic cellsCytokine release syndromeInfusion reactions
06
Interacting drugs
Tagraxofusp
1 more in the full profile.
07
Biomarkers
Diagnosis of AMLDiagnosis of BPDCNMonitoring treatment response in CD123-positive malignancies
Beyond the preview
Go deeper on Interleukin-3 Receptor Alpha Subunit (IL3RA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Interleukin-3 Receptor Alpha Subunit (IL3RA).